Healthcare provider profile · identity verified

Kate E Frueh Miller, DO

Family Practice · ENGLEWOOD, CO · NPI 1487700092

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	306	84
Atorvastatin Calcium	Atorvastatin Calcium	276	76
Lisinopril	Lisinopril	179	54
Rosuvastatin Calcium	Rosuvastatin Calcium	168	59
Simvastatin	Simvastatin	147	41
Alendronate Sodium	Alendronate Sodium	142	47
Omeprazole	Omeprazole	141	51
Amlodipine Besylate	Amlodipine Besylate	135	45
Losartan Potassium	Losartan Potassium	120	38
Metformin Hcl	Metformin Hcl	120	39
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	117	37
Gabapentin	Gabapentin	92	37
Meloxicam	Meloxicam	85	35
Metoprolol Tartrate	Metoprolol Tartrate	84	25
Albuterol Sulfate Hfa	Albuterol Sulfate	83	47
Pradaxa	Dabigatran Etexilate Mesylate	82	29
Duloxetine Hcl	Duloxetine Hcl	81	29
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	75	21
Furosemide	Furosemide	73	23
Oxycodone Hcl	Oxycodone Hcl	72	11
Sertraline Hcl	Sertraline Hcl	70	23
Citalopram Hbr	Citalopram Hydrobromide	64	18
Glipizide	Glipizide	63	22
Pantoprazole Sodium	Pantoprazole Sodium	58	19
Trazodone Hcl	Trazodone Hcl	57	17
Metformin Hcl Er	Metformin Hcl	55	17
Tramadol Hcl	Tramadol Hcl	54	11
Potassium Chloride	Potassium Chloride	50	16
Allopurinol	Allopurinol	49	13
Acyclovir	Acyclovir	48	20
Hydrochlorothiazide	Hydrochlorothiazide	46	15
Estradiol	Estradiol	44	17
Mirtazapine	Mirtazapine	44	15
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	44	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	41	11
Atenolol	Atenolol	39	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	39	suppressed
Metoprolol Succinate	Metoprolol Succinate	38	14
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	35	35
Tamsulosin Hcl	Tamsulosin Hcl	35	14
Fluticasone Propionate	Fluticasone Propionate	33	13
Arexvy	Rsvpref3 Antigen/As01e/Pf	32	32
Ondansetron Odt	Ondansetron	30	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	29	11
Triamcinolone Acetonide	Triamcinolone Acetonide	29	22
Bupropion Xl	Bupropion Hcl	28	13
Ozempic	Semaglutide	28	suppressed
Warfarin Sodium	Warfarin Sodium	28	suppressed
Ezetimibe	Ezetimibe	27	suppressed
Propranolol Hcl	Propranolol Hcl	27	suppressed
Trospium Chloride	Trospium Chloride	27	suppressed
Jardiance	Empagliflozin	26	suppressed
Celecoxib	Celecoxib	25	suppressed
Humulin N	Insulin Nph Human Isophane	25	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	25	23
Alvesco	Ciclesonide	24	12
Spiriva Respimat	Tiotropium Bromide	24	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	23	suppressed
Famotidine	Famotidine	22	11
Lovastatin	Lovastatin	22	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Verapamil Er	Verapamil Hcl	20	suppressed
Solifenacin Succinate	Solifenacin Succinate	19	suppressed
Spironolactone	Spironolactone	19	suppressed
Carvedilol	Carvedilol	18	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	17	suppressed
Glimepiride	Glimepiride	17	suppressed
Prednisone	Prednisone	17	16
Finasteride	Finasteride	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	16	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	15	suppressed
Cefuroxime	Cefuroxime Axetil	14	14
Clopidogrel	Clopidogrel Bisulfate	13	suppressed
Budesonide Dr	Budesonide	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Donepezil Hcl	Donepezil Hcl	12	suppressed
Oxycontin	Oxycodone Hcl	12	suppressed
Buprenorphine	Buprenorphine	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Repatha Sureclick	Evolocumab	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error